Showing results (71-80 of 226) with videos related to
Sort By:
Pageof 23
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 25, 2018
[Gene mutations from 511 myelodysplastic syndromes patients performed by targeted gene sequencing]B Li, J Y Wang, J Q Liu, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 3, 2025
[Clinical and molecular characteristics of myeloproliferative neoplasms patients with NFE2 gene mutations]S Y Zhao, B Li, Z F Xu, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 2, 2019
[A study of clinical characteristics and prognosis of primary myelofibrosis patients with thrombocytopenia in varied degrees]Z F Xu, T J Qin, H L Zhang, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 19, 2016
[Prognostic value of JAK2, MPL and CALR mutations in Chinese patients with primary myelofibrosis]Z F Xu, B Li, J Q Liu, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 6, 2026
[Clinical characteristics and prognosis of myelodysplastic neoplasms with GATA2 mutations]J Tang, Y J Jia, T J Qin, et al.Oncogene|July 17, 2012
CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancerC Xie, X H Jiang, J T Zhang, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 20, 2022
[Health-related quality of life and its associated variables in Chinese patients with Philadelphia-negative myeloproliferative neoplasms]M Bao, D Y Shi, H X Shi, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 25, 2023
[Clinical and genetic characteristics of young patients with myeloproliferative neoplasms]M Y Zhang, M Bao, D Y Shi, et al.Physical Review Letters|May 21, 2010
Measurements of h(c)(1P(1)) in psi' decaysM Ablikim, M N Achasov, L An, et al.Physical Review Letters|January 15, 2011
Evidence for ψ' decays into γπ0 and γηM Ablikim, M N Achasov, L An, et al.Pageof 23